Skip to main content

Table 3 Efficacy outcomes of visual analogue total ocular symptom scores

From: Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study

Characteristics

FUP (n = 30)

BUD (n = 32)

P value

VATOSS

Watery eyes

Baseline

7.59 ± 1.51

7.30 ± 1.53

0.45

4th week

5.09 ± 1.51

6.09 ± 1.57

0.01

8th week

2.80 ± 1.22

4.80 ± 1.64

< 0.0001

P value

< 0.0001

< 0.0001

 

Redness

Baseline

7.78 ± 1.54

7.47 ± 1.55

0.43

4th week

5.46 ± 1.46

6.31 ± 1.59

0.03

8th week

3.32 ± 1.37

5.14 ± 1.60

< 0.0001

P value

< 0.0001

< 0.0001

 

Burning

Baseline

6.90 ± 1.40

6.60 ± 1.39

0.4

4th week

4.67 ± 1.26

5.49 ± 1.44

0.02

8th week

2.49 ± 1.18

4.43 ± 1.53

< 0.0001

P value

< 0.0001

< 0.0001

 

Itching eyes

Baseline

6.73 ± 1.42

6.65 ± 1.60

0.83

4th week

4.44 ± 1.40

5.50 ± 1.66

0.008

8th week

2.43 ± 1.37

4.38 ± 1.69

< 0.0001

P value

< 0.0001

< 0.0001

 
  1. Data are shown as mean ± standard deviation as appropriate. Unpaired T test was used to determine significance
  2. VATOSS Visual Analogue Total Ocular Symptom Score, FUP Fluticasone propionate, BUD Budesonide